Lv5
840 积分 2023-05-25 加入
Screening for familial hypercholesterolemia in the era of artificial intelligence: A contemporary narrative review
9小时前
已完结
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials
9小时前
已完结
Polygenic risk scores in familial hypercholesterolemia. Do they have a role?
9小时前
已关闭
An overview of familial hypercholesterolemia in children and adolescents. The story so far
9小时前
已关闭
Recent advances in research and care of familial hypercholesterolaemia
9小时前
已完结
Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association
9小时前
已完结
Breaking barriers: Innovative therapies for managing homozygous familial hypercholesterolemia
9小时前
已完结
Update on genetics of familial hypercholesterolemia
9小时前
已完结
Lipoprotein(a) in familial hypercholesterolemia
9小时前
已完结
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia
9小时前
已完结
皖公网安备34019202002308
